A two-day student symposium returned to the Kennedy Institute bringing together students and peers from across the department to discuss their latest research.
Building work at the Kennedy Institute of Rheumatology has finished, providing a new third floor that houses additional meeting and collaboration space for data science and offices for the management of clinical trials.
Professor Michael Dustin and an international team of collaborators have been awarded a \u20ac10M grant from the European Research Council (ERC) to develop a new biotechnology around supramolecular attack particles (SMAPs) engineered to kill cancer cells.
Five new Oxford-Bristol Myers Squibb Fellowships representing an investment of \u00a33M have been announced. The fellowships (formerly Oxford-Celgene) will support postdoctoral researchers and clinicians across five departments within the Medical Sciences Division and the Mathematical, Physical and Life Sciences Division, providing an opportunity for them to gain exposure to the field of commercial drug discovery and development.
Dr Rahul Ravindran has been awarded a highly competitive MRC Clinical Research Training Fellowship, following a successful research placement at the Kennedy Institute in 2019.
A building project to extend the Kennedy Institute of Rheumatology building with a new floor will create much needed space for the Institute to expand, particularly in the areas of data science and clinical trials.
Kennedy research Professor Irina Udalova has joined the Wellcome Trust\u2019s Immune System in Health and Disease Expert Review Group from 1 October 2018.
NDORMS ran two work experience weeks for eleven Y12 students from local state schools. While they were here they created video diaries about their week.
Dr Luke Jostins joins the Kennedy Institute to lead a new research group that will develop statistical methods to decode the genetics of complex immune diseases.
A new partnership has been formed between the Universities of Oxford and Birmingham to speed up the development of novel treatments for arthritis, supported by a \u00a37 million investment from the Kennedy Trust for Rheumatology Research.
![\"Student](\"https://www.kennedy.ox.ac.uk/news/the-kennedy-institute-student-symposium-returns-for-its-5th-year/responsive_image?ratio=r16x9&scale=w760\")
\n \n \n\n\n